Exelixis
EXEL
#1827
Rank
S$14.81 B
Marketcap
S$55.24
Share price
-1.20%
Change (1 day)
12.25%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total assets

Total assets on the balance sheet as of December 2025 : S$3.60 Billion

According to Exelixis's latest financial reports the company's total assets are S$3.60 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exelixis - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31S$3.65 B-8.85%
2024-12-31S$4.00 B3.11%
2023-12-31S$3.88 B-5.63%
2022-12-31S$4.11 B16.42%
2021-12-31S$3.53 B25.09%
2020-12-31S$2.82 B11.22%
2019-12-31S$2.54 B30.84%
2018-12-31S$1.94 B121.69%
2017-12-31S$0.87 B1.65%
2016-12-31S$0.86 B83.41%
2015-12-31S$0.47 B10.06%
2014-12-31S$0.42 B-33.01%
2013-12-31S$0.63 B-27.69%
2012-12-31S$0.88 B73.15%
2011-12-31S$0.50 B9.59%
2010-12-31S$0.46 B-3.6%
2009-12-31S$0.48 B-16.06%
2008-12-31S$0.57 B-3.15%
2007-12-31S$0.59 B-2.19%
2006-12-31S$0.60 B9.45%
2005-12-31S$0.55 B16.55%
2004-12-31S$0.47 B-21.81%
2003-12-31S$0.60 B3.31%
2002-12-31S$0.58 B-8.3%
2001-12-31S$0.64 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
S$252.23 B 6,903.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$264.29 B 7,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$114.13 B 3,069.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$192.87 B 5,255.19%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$164.03 B 4,454.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$114.00 B 3,065.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$104.41 B 2,799.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
S$34.99 M-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
S$0.12 B-96.44%๐Ÿ‡บ๐Ÿ‡ธ USA